Xolair, an injection, is now available to adults and children 1 year and older to reduce risk of severe allergic reactions to foods, the FDA announced in a news release. Xolair, the brand name for ...

The FDA has approved Xolair to help prevent allergic reactions in people with severe food allergies. The medication is an injection that’s taken every two or four weeks. It’s available by ...

Joshua Cohen is a Boston-based writer who covers health policy. Two weeks ago, the Food and Drug Administration approved Xolair (omalizumab) for immunoglobulin E-mediated food allergy in certain ...

Xolair (omalizumab) generated revenues of more ... which is available in markets in the US and EU as a subcutaneous injection lasting a few minutes, instead of a lengthy infusion.

The approved dose is 300 mg by subcutaneous injection every four weeks. "The EU approval of Xolair in CSU is truly exciting for patients with this chronic and debilitating skin disease," said ...

The key is a drug originally designed to treat asthma patients. "The way that omalizumab, brand name Xolair, works is that it binds to your allergy cells, and it takes it out of circulation ...